Clinical Trial: Effect of Integrated Neuromuscular Inhibition Technique on Scapular Dyskinesia Type 2

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232316) titled 'Effect of Integrated Neuromuscular Inhibition Technique on Scapular Dyskinesia Type 2' on Sept. 23.

Brief Summary: The goal of this clinical trial is to learn whether the Integrated Neuromuscular Inhibition Technique (INIT) can influence shoulder motion, muscle strength, and scapular positioning in young adults with Scapular Dyskinesis Type II. This study will also compare INIT with a conventional exercise program.

The main questions the study aims to answer are:

* Does INIT affect shoulder range of motion compared with conventional exercise?

* Does INIT affect shoulder-girdle muscle strength?

* Does INIT influence scapular devi...